Table 4.
Incidence of Nonhematological Adverse Events (n = 41, Total = 308)
| Grade | 1 | 2 | 3 | 4 |
|---|---|---|---|---|
| Gastrointestinal disorder | ||||
| Nausea/vomit | 13 (31.7%) | 5 (12.2%) | ||
| Anorexia | 9 (22.0%) | 6 (14.6%) | ||
| Diarrhea | 2 (4.9%) | 2 (4.9%) | ||
| General disorders | ||||
| General fatigue | 7 (17.1%) | 4 (9.8%) | ||
| Alopecia | 5 (12.2%) | |||
| Skin and subcutaneous disorders | ||||
| Pigmentation | 12 (29.3%) | 1 (2.4%) | ||
| Skin induration | 7 (17.1%) | |||
| Nervous system disorders | ||||
| Peripheral sensory neuropathy | 15 (36.6%) | 19 (46.3%) | 7 (17.1%) | |
| Paresthesia | 24 (58.5%) | 7 (17.1%) | ||
| Dizziness | 8 (19.5%) | |||
| Dysgeusia | 13 (31.7%) | 2 (4.9%) | ||